Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-DP for ocular inflammation and pain after cataract surgery
NCT02736175Phase 3Completed
- Sponsor
- Ocular Therapeutix
- Start
- Oct 2015
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in ocular inflammation comparing OTX-DP with Placebo (2 arms). Primary endpoints: Absence of Anterior Chamber Inflammation at Day 14 and Absence of Ocular Pain at Day 8. Started Oct 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT02736175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736175.